» Authors » Tomomi Aoshika

Tomomi Aoshika

Explore the profile of Tomomi Aoshika including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 103
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryuno Y, Abe T, Tsukahara K, Watanabe J, Iino M, Saito S, et al.
Anticancer Res . 2025 Mar; 45(3):1127-1136. PMID: 40037876
Background/aim: Liver metastases are a major cause of cancer-related mortality and present significant therapeutic challenges. Chemotherapy is preferred for multiple metastases, while surgery or stereotactic body radiotherapy (SBRT) is used...
2.
Aoshika T, Noda S, Abe T, Kumazaki Y, Hirai R, Igari M, et al.
Anticancer Res . 2024 Mar; 44(4):1583-1589. PMID: 38537975
Background/aim: Concurrent cisplatin-based chemoradiotherapy (CCRT) is the standard treatment for locally advanced cervical cancer. Especially, CCRT with magnetic resonance imaging (MRI) or computed tomography-based image-guided brachytherapy (CT-based 3D-IGBT) for cervical...
3.
Igari M, Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, et al.
Thorac Cancer . 2023 Jul; 14(26):2642-2647. PMID: 37466172
Background: Intensity-modulated radiotherapy (IMRT) has been increasingly used for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, there are some barriers to implementing IMRT for LA-NSCLC, including the...
4.
Hirai R, Ohta T, Igari M, Kumazaki Y, Iino M, Aoshika T, et al.
Anticancer Res . 2023 Jun; 43(7):3265-3271. PMID: 37351988
Background/aim: Combined intracavitary and interstitial brachytherapy (IC/IS-BT) is an effective treatment for extensive and bulky cervical cancer. However, the optimum number of interstitial needle applicators ("needles") inserted in IC/IS-BT can...
5.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, et al.
Anticancer Res . 2023 Jan; 43(2):675-682. PMID: 36697072
Background/aim: Efficacy and toxicity of concurrent chemoradiotherapy (CCRT) and durvalumab for locally advanced non-small cell lung cancer (LA-NSCLC) with N3 lymph node metastasis remain unclear. We aimed to evaluate the...
6.
Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, et al.
J Gynecol Oncol . 2023 Jan; 34(3):e24. PMID: 36603849
Objective: The purposes of this trial were to demonstrate the feasibility and effectiveness of the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer patients in the...
7.
Aoshika T, Abe T, Iino M, Saito S, Ryuno Y, Ohta T, et al.
Anticancer Res . 2022 Dec; 42(12):6099-6103. PMID: 36456125
Background/aim: Palliative radiotherapy is one of the effective treatments for pelvic tumors with bleeding or pain. In this study, we evaluated the safety and efficacy of palliative radiotherapy (RT) for...
8.
Okonogi N, Murakami N, Ando K, Murata M, Murata K, Aoshika T, et al.
J Contemp Brachytherapy . 2022 Oct; 14(4):311-320. PMID: 36199951
Purpose: There are limited reports on outcomes of three-dimensional image-guided brachytherapy (3D-IGBT) for cervical adenocarcinoma in Asia. In a multi-institutional retrospective study, we assessed the clinical outcomes of three-dimensional image-guided...
9.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, et al.
Thorac Cancer . 2022 Sep; 13(20):2890-2896. PMID: 36054298
Background: In this study, we developed a simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer (NSCLC) treated with...
10.
Aoshika T, Noda S, Abe T, Kumazaki Y, Hirai R, Igari M, et al.
Brachytherapy . 2022 Aug; 21(6):783-791. PMID: 35927196
Purpose: To evaluate treatment results and investigate predictors of local control. Methods And Materials: In this retrospective study of 236 patients with cervical cancer, we administered CT-based adaptive brachytherapy (BT)...